SEC Form D private-offering filing

Avenue Biosciences Holding Inc

Name: Avenue Biosciences Holding Inc - new SEC Form D private-offering filing, Menlo Park, CA
Published: 2026-01-28

A new SEC Form D private-offering notice from Menlo Park, CA, a $8,357,349 filer-stated offering target in Biotech. The source filing is one click away.

Avenue Biosciences Holding Inc site↗ Verified via SEC Form D

Develops a protein engineering platform that optimizes the secretory pathway to improve therapeutic protein manufacturing, using a library of engineered signal peptides and machine learning.

Filed 2026-01-28Filed to raise $8,357,349First money in 2025-11-20Raised so far $7,440,682HQ (as filed) Menlo Park, CASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified avenuebiosciences.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.